Average Co-Inventor Count = 11.57
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Pharma Aktiengesellschaft (12 from 378 patents)
2. Bayer Aktiengesellschaft (7 from 12,164 patents)
3. Harvard College (6 from 2,967 patents)
4. The General Hospital Corporation (6 from 2,893 patents)
5. The Broad Institute, Inc. (6 from 444 patents)
6. Bayer Intellectual Property Gmbh (4 from 721 patents)
7. Bayer Schering Pharma Ag (2 from 192 patents)
8. Deutsches Krebsforschungszentrum (2 from 155 patents)
9. Bayer Aktiengellschaft (1 from 5 patents)
10. Bayer Pharma Aktiengessellschaft (1 from 2 patents)
11. Bayer Pharma Aktiengellschaft (1 from 1 patent)
12. Bayer Pharma Aktiegellschaft (1 from 1 patent)
21 patents:
1. 12486248 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
2. 12006304 - Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugs
3. 12006303 - Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugs
4. 11787797 - 4,5-annulated 1,2,4-triazolones
5. 11713304 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
6. 11524944 - 2-phenylpyrimidine-4-carboxamides as AHR inhibitors
7. 11304946 - 2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonists
8. 11130745 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
9. 10968216 - 4,5-annulated 1,2,4-triazolones
10. 10815215 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
11. 10793545 - Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
12. 10435396 - 2-substituted indazoles, methods for producing same, pharmaceutical preparations that contain same, and use of same to produce drugs
13. 10370339 - N-Methylbenzimidazoles as mIDH1 inhibitors
14. 10308634 - Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
15. 9951086 - Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicaments